Jump to content

Hemoperfusion: Difference between revisions

From Wikipedia, the free encyclopedia
Browse history interactively
← Previous editNext edit →
Content deleted Content added
VisualWikitext
No edit summary
m →‎Complications: Added addition heading for better clarity
Line 25: Line 25:
Complications of hemoperfusion may include [[thrombocytopenia]], [[leucopenia]], [[hypoglycemia]], and some reduction in clotting factors, with recovery typically
Complications of hemoperfusion may include [[thrombocytopenia]], [[leucopenia]], [[hypoglycemia]], and some reduction in clotting factors, with recovery typically
occuring in 1-2 days. Risk of bleeding is also higher because of high heparin dose and reduction in platelets and clotting factors.<ref>Manual of Clinical Dialysis, Second Edition, Ch. 16.2.3.2, pp.231-232 Springer, Suhail Ahmad, University of Washington, Scribner Kidney Center, Northwest Kidney Centers, Seattle, Washington, USA </ref>
occuring in 1-2 days. Risk of bleeding is also higher because of high heparin dose and reduction in platelets and clotting factors.<ref>Manual of Clinical Dialysis, Second Edition, Ch. 16.2.3.2, pp.231-232 Springer, Suhail Ahmad, University of Washington, Scribner Kidney Center, Northwest Kidney Centers, Seattle, Washington, USA </ref>

== Indications for Use ==


During hemoperfusion, the blood passes through a column with absorptive properties aiming at removing specific toxic substances from the patient’s blood. It especially targets small- to medium-sized [[molecules]] that tend to be more difficult to remove by conventional [[hemodialysis]]. The adsorbent substance most commonly used in hemoperfusion are resins and [[activated carbon]].<ref>{{cite journal |author=Rahman MH, Haqqie SS, McGoldrick MD |title=Acute hemolysis with acute renal failure in a patient with valproic acid poisoning treated with charcoal hemoperfusion |journal=Hemodialysis international. International Symposium on Home Hemodialysis |volume=10 |issue=3 |pages=256–9 |year=2006 |pmid=16805886 |doi=10.1111/j.1542-4758.2006.00105.x}}</ref> Hemoperfusion is an [[extracorporeal]] form of treatment because the blood is pumped through a device outside the patient's body.
During hemoperfusion, the blood passes through a column with absorptive properties aiming at removing specific toxic substances from the patient’s blood. It especially targets small- to medium-sized [[molecules]] that tend to be more difficult to remove by conventional [[hemodialysis]]. The adsorbent substance most commonly used in hemoperfusion are resins and [[activated carbon]].<ref>{{cite journal |author=Rahman MH, Haqqie SS, McGoldrick MD |title=Acute hemolysis with acute renal failure in a patient with valproic acid poisoning treated with charcoal hemoperfusion |journal=Hemodialysis international. International Symposium on Home Hemodialysis |volume=10 |issue=3 |pages=256–9 |year=2006 |pmid=16805886 |doi=10.1111/j.1542-4758.2006.00105.x}}</ref> Hemoperfusion is an [[extracorporeal]] form of treatment because the blood is pumped through a device outside the patient's body.

Revision as of 20:18, 22 April 2015

Hemoperfusion
MeSHD006464

Hemoperfusion (British English: haemoperfusion) First introduced in the 1940s, the technique was refined during 1950 to 1970, and then introduced clinically for the treatment of poisoning in the 1970s and 1980s. It is sometimes used in drug overdose possibly in conjunction with other extracorporeal techniques such as hemodialysis(HD), peritoneal dialysis(PD), hemofiltration(HF), and hemodiafiltration(HDF).[1]

Two types of hemoperfusion are commonly used:

1) Charcoal hemoperfusion, which has been used to treat liver (hepatic) failure, various types of poisoning, and certain autoimmune diseases when coated with antigens or antibodies.

2) Certain resins(Polystyrene - XAD series) are frequently more efficient at clearing lipid soluble drugs than charcoal hemoperfusion.

Hemoperfusion is also used in the treatment of specific intoxications, such as valproic acid, theophylline, and meprobamate.

[2][3]

Despite its availability, this technique is only infrequently utilized as a medical process used to remove toxic substances from a patient's blood.[4]

Complications

Complications of hemoperfusion may include thrombocytopenia, leucopenia, hypoglycemia, and some reduction in clotting factors, with recovery typically occuring in 1-2 days. Risk of bleeding is also higher because of high heparin dose and reduction in platelets and clotting factors.[5]

Indications for Use

During hemoperfusion, the blood passes through a column with absorptive properties aiming at removing specific toxic substances from the patient’s blood. It especially targets small- to medium-sized molecules that tend to be more difficult to remove by conventional hemodialysis. The adsorbent substance most commonly used in hemoperfusion are resins and activated carbon.[6] Hemoperfusion is an extracorporeal form of treatment because the blood is pumped through a device outside the patient's body.

Its major uses include removing drugs or poisons from the blood in emergency situations, removing waste products from the blood in patients with kidney failure, and as a supportive treatment for patients before and after liver transplantation.[7]

References

  1. ^ Manual of Clinical Dialysis, Second Edition, Ch. 16.2, pp. 229-232 Springer, Suhail Ahmad, University of Washington, Scribner Kidney Center, Northwest Kidney Centers, Seattle, Washington, USA
  2. ^ Manual of Clinical Dialysis, Second Edition, Ch. 16.2.3, pp.229-232 Springer, Suhail Ahmad, University of Washington, Scribner Kidney Center, Northwest Kidney Centers, Seattle, Washington, USA
  3. ^ http://cursoenarm.net/UPTODATE/contents/mobipreview.htm?10/53/11102
  4. ^ http://www.uptodate.com/contents/hemoperfusion
  5. ^ Manual of Clinical Dialysis, Second Edition, Ch. 16.2.3.2, pp.231-232 Springer, Suhail Ahmad, University of Washington, Scribner Kidney Center, Northwest Kidney Centers, Seattle, Washington, USA
  6. ^ Rahman MH, Haqqie SS, McGoldrick MD (2006). "Acute hemolysis with acute renal failure in a patient with valproic acid poisoning treated with charcoal hemoperfusion". Hemodialysis international. International Symposium on Home Hemodialysis. 10 (3): 256–9. doi:10.1111/j.1542-4758.2006.00105.x. PMID 16805886.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  7. ^ http://www.gambro.com/en/global/Therapies/Hemoperfusion1/



Stub icon

This medical treatment–related article is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Hemoperfusion&oldid=658706162"